Completed NA INTERVENTIONAL 1-arm NCT03284619

First-In Man (FIM) Study MR-Linac (FIM MR-Linac)

Sponsor: Factory CRO for Medical Devices B.V.

Interventions Magnetic resonance imager linear accelerator

Updated 6 times since 2017 Last updated: Mar 27, 2018 Started: Apr 1, 2017 Primary completion: Jul 11, 2017 Completion: Sep 8, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Bone Metastases and is currently completed. Factory CRO for Medical Devices B.V. leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Apr 2018 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Oct 2017 — Apr 2018 [monthly]

Active Not Recruiting NA

First recorded

Apr 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Factory CRO for Medical Devices B.V.
Nucletron Operations BV

Data source: Nucletron Operations BV

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Utrecht, Netherlands